Form 4: Core Labs CFO Vests Performance Shares

Core Laboratories' SVP & CFO, Christopher Scott Hill, vested 61,417 performance shares and disposed of 32,152 shares for tax purposes.

Summary

• Christopher Scott Hill, SVP & CFO of Core Laboratories Inc., reported transactions involving the company's common stock.
• On December 31, 2025, 61,417 performance shares vested, resulting in the acquisition of 61,417 shares of common stock at an exercise price of $0.
• These performance shares were originally awarded in February 2023 and vested because Core Laboratories achieved the 68th percentile in return on invested capital among its Bloomberg Peer Group, exceeding the target award level by 116.5%.
• Concurrently, 32,152 shares of common stock were disposed of at a price of $16.03 per share, likely for tax withholding purposes related to the vesting.
• Following these transactions, Christopher Scott Hill beneficially owns 142,354 shares of Core Laboratories Inc. common stock directly.

Sentiment

Score: 7

Explanation: The vesting of performance shares at 116.5% of the target award level, driven by achieving the 68th percentile in ROIC against peers, indicates strong company performance and effective executive incentive alignment. The disposition of shares is a standard tax-related event.

Positives

• The vesting of 61,417 performance shares indicates the company met its performance criteria, specifically achieving the 68th percentile in return on invested capital among its Bloomberg Peer Group.
• The performance criteria were satisfied at 116.5% of the target award level, demonstrating strong execution against set goals.

Negatives

• A disposition of 32,152 shares of common stock occurred, likely for tax obligations, reducing the immediate direct holding of the insider.

Future Outlook

This filing does not contain forward-looking statements or guidance, as it reports historical insider transactions.

Management Comments

• The Company finished in the 68th percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2025.
• The performance criteria and requirements for vesting have been satisfied at 116.5% of the target award level, and such number of shares vested on December 31, 2025.

Industry Context

This Form 4 details a routine executive compensation event, reflecting the company's performance against pre-established metrics rather than broader industry trends. It primarily signals internal corporate governance and executive incentive alignment.

Comparison to Industry Standards

• Core Laboratories achieved the 68th percentile of return on invested capital among its Bloomberg Peer Group, indicating above-average performance relative to its industry peers. This specific metric and peer group comparison are directly stated in the filing.

Stakeholder Impact

• Shareholders: Positive, as it demonstrates management's incentives are aligned with company performance and that performance targets were met, potentially indicating sound corporate governance.
• Employees: May signal a positive internal environment if performance-based compensation is widespread, potentially boosting morale and retention.

Key Dates

Keywords

Core Laboratories, CLB, Form 4, Insider Transaction, Performance Shares, Executive Compensation, Return on Invested Capital